• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Halyard Health

Anonymous board for Halyard Health
Replies
5
Views
6K
anonymous
Replies
4
Views
8K
anonymous
Replies
4
Views
6K
anonymous
Replies
0
Views
2K
anonymous
Replies
1
Views
3K
anonymous
Replies
0
Views
2K
anonymous
Replies
1
Views
3K
anonymous
Replies
0
Views
3K
anonymous
Replies
5
Views
4K
anonymous
Replies
1
Views
5K
anonymous
Replies
1
Views
3K
anonymous
Replies
23
Views
11K
Anonymous
Replies
5
Views
6K
Anonymous
Replies
0
Views
3K
Anonymous
Replies
4
Views
6K
Anonymous
Replies
13
Views
6K
Anonymous